Literature DB >> 8453668

Binding affinities and cooperative interactions with bHLH activators delimit threshold responses to the dorsal gradient morphogen.

J Jiang1, M Levine.   

Abstract

The dorsal (dl) morphogen gradient initiates the formation of the mesoderm, neuroectoderm, and dorsal ectoderm by setting different limits of regulatory gene expression along the dorsoventral axis of the early Drosophila embryo. In this paper, we show that low affinity dl-binding sites restrict target gene expression to the ventralmost regions (presumptive mesoderm), where there are peak levels of dl, while high affinity sites permit expression in ventrolateral regions (mesoderm and mesectoderm) containing intermediate levels of the morphogen. Activation by low levels of dl in lateral regions (the presumptive neuroectoderm) depends on cooperative DNA binding interactions between dl and bHLH proteins. The snail repressor blocks this interaction and restricts expression to the neuroectoderm. We discuss how enhancers serve as templates to bring weakly interacting regulatory factors into close proximity so that they can function combinatorially to activate and repress transcription.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453668     DOI: 10.1016/0092-8674(93)90402-c

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  126 in total

1.  Complex organization of promoter and enhancer elements regulate the tissue- and developmental stage-specific expression of the Drosophila melanogaster Gld gene.

Authors:  B L Keplinger; X Guo; J Quine; Y Feng; D R Cavener
Journal:  Genetics       Date:  2001-02       Impact factor: 4.562

2.  A GATA-2/estrogen receptor chimera functions as a ligand-dependent negative regulator of self-renewal.

Authors:  C Heyworth; K Gale; M Dexter; G May; T Enver
Journal:  Genes Dev       Date:  1999-07-15       Impact factor: 11.361

3.  Genome-wide analysis of clustered Dorsal binding sites identifies putative target genes in the Drosophila embryo.

Authors:  Michele Markstein; Peter Markstein; Vicky Markstein; Michael S Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

4.  CtBP-dependent activities of the short-range Giant repressor in the Drosophila embryo.

Authors:  Y Nibu; M S Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

5.  An anteroposterior Dorsal gradient in the Drosophila embryo.

Authors:  A M Huang; J Rusch; M Levine
Journal:  Genes Dev       Date:  1997-08-01       Impact factor: 11.361

6.  The gypsy insulator can function as a promoter-specific silencer in the Drosophila embryo.

Authors:  H N Cai; M Levine
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

7.  Quantitatively predictable control of Drosophila transcriptional enhancers in vivo with engineered transcription factors.

Authors:  Justin Crocker; Garth R Ilsley; David L Stern
Journal:  Nat Genet       Date:  2016-02-08       Impact factor: 38.330

8.  BDNF rs6265 methylation and genotype interact on risk for schizophrenia.

Authors:  Gianluca Ursini; Tommaso Cavalleri; Leonardo Fazio; Tiziana Angrisano; Luisa Iacovelli; Annamaria Porcelli; Giancarlo Maddalena; Giovanna Punzi; Marina Mancini; Barbara Gelao; Raffaella Romano; Rita Masellis; Francesca Calabrese; Antonio Rampino; Paolo Taurisano; Annabella Di Giorgio; Simona Keller; Letizia Tarantini; Lorenzo Sinibaldi; Tiziana Quarto; Teresa Popolizio; Grazia Caforio; Giuseppe Blasi; Marco A Riva; Antonio De Blasi; Lorenzo Chiariotti; Valentina Bollati; Alessandro Bertolino
Journal:  Epigenetics       Date:  2016-02-18       Impact factor: 4.528

Review 9.  Gene regulatory networks for development.

Authors:  Michael Levine; Eric H Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-23       Impact factor: 11.205

10.  cis-regulatory logic of short-range transcriptional repression in Drosophila melanogaster.

Authors:  Meghana M Kulkarni; David N Arnosti
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.